Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound

Frontiers in Neuroscience
Gianina LucaM Tafti

Abstract

Psychostimulants are used for the treatment of excessive daytime sleepiness in a wide range of sleep disorders as well as in attention deficit hyperactivity disorder or cognitive impairment in neuropsychiatric disorders. Here, we tested in mice the wake-promoting properties of NLS-4 and its effects on the following sleep as compared with those of modafinil and vehicle. C57BL/6J mice were intraperitoneally injected with vehicle, NLS-4 (64 mg/kg), or modafinil (150 mg/kg) at light onset. EEG and EMG were recorded continuously for 24 h after injections and vigilance states as well as EEG power densities were analyzed. NLS-4 at 64 mg/kg induced significantly longer wakefulness duration than modafinil at 150 mg/kg. Although no significant sleep rebound was observed after sleep onset for both treatments as compared with their vehicles, modafinil-treated mice showed significantly more NREM sleep when compared to NLS-4. Spectral analysis of the NREM EEG after NLS-4 treatment indicated an increased power density in delta activity (0.75-3.5 Hz) and a decreased power in theta frequency range (6.25-7.25 Hz), while there was no differences after modafinil treatment. Also, time course analysis of the delta activity showed a significant incre...Continue Reading

References

May 4, 2006·The Journal of Clinical Psychiatry·Jacob S Ballon, David Feifel
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael J Minzenberg, Cameron S Carter
Feb 6, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sibah HasanPaul Franken
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie VienneMehdi Tafti
Oct 11, 2013·Lancet Neurology·Yves DauvilliersUNKNOWN HARMONY I study group
Jan 1, 2012·Current Protocols in Mouse Biology·Géraldine Morgane Mang, Paul Franken
Aug 23, 2016·The European Journal of Neuroscience·Maddalena MereuGianluigi Tanda
Aug 24, 2016·Current Treatment Options in Neurology·Lucie BarateauYves Dauvilliers

❮ Previous
Next ❯

Citations

Jul 14, 2020·Frontiers in Neuroscience·Anna Ashton, Aarti Jagannath

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
EMBLA
Somnologica
ClockLab

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

© 2022 Meta ULC. All rights reserved